Takeda Escapes Antitrust Suit Over IBS Drug
By Julie Manganis · November 21, 2023, 2:38 PM EST
A Massachusetts federal judge on Monday tossed a Blue Cross affiliate's proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of constipation drug Amitiza off the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login